Related references
Note: Only part of the references are listed.An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
Timothy C. Hallstrom et al.
CANCER CELL (2008)
Targeted deletion reveals essential and overlapping functions of the miR-17∼92 family of miRNA clusters
Andrea Ventura et al.
CELL (2008)
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
Changchun Xiao et al.
NATURE IMMUNOLOGY (2008)
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines
S. Nagel et al.
LEUKEMIA (2008)
Lentivirus-mediated antagomir expression for specific inhibition of miRNA function
Michaela Scherr et al.
NUCLEIC ACIDS RESEARCH (2007)
Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells
Letizia Venturini et al.
BLOOD (2007)
Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1
Stefan Nagel et al.
CANCER RESEARCH (2007)
HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32)
Xin-Ying Su et al.
BLOOD (2006)
RNA-mediated gene silencing in hematopoietic cells
Letizia Venturini et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia
I Riz et al.
ONCOGENE (2005)
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (TALL)
J Soulier et al.
BLOOD (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
c-Myc-regulated microRNAs modulate E2F1 expression
KA O'Donnell et al.
NATURE (2005)
The E2F-1 transcription factor promotes caspase-8 and Bid expression, and enhances Fas signaling in T cells
QY Cao et al.
JOURNAL OF IMMUNOLOGY (2004)
A microarray model system identifies potential new target genes of the proto-oncogene HOX11
K Hoffmann et al.
GENES CHROMOSOMES & CANCER (2004)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
Gene expression profiling in T-cell acute lymphoblastic leukemia
AA Ferrando et al.
SEMINARS IN HEMATOLOGY (2003)
Activation of HOX11L2 by juxtaposition with 3′-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2)
RAF MacLeod et al.
GENES CHROMOSOMES & CANCER (2003)
Disruption of the RanBP17/Hox11L2 region by recombination with the TCRδ locus in acute lymphoblastic leukemias with t(5;14)(q34;q11)
TE Hansen-Hagge et al.
LEUKEMIA (2002)
Deregulated homeobox gene expression in cancer: Cause or consequence?
C Abate-Shen
NATURE REVIEWS CANCER (2002)
HOX11L2 expression, defines a clinical subtype of pediatric T-ALL associated with poor prognosis
P Ballerini et al.
BLOOD (2002)
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
AA Ferrando et al.
CANCER CELL (2002)
A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia
OA Bernard et al.
LEUKEMIA (2001)
Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes
BY Bi et al.
IMMUNOLOGY (2001)
Homeobox genes in normal and malignant cells
C Cillo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
NA Lissy et al.
NATURE (2000)
The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase
XD Wang et al.
JOURNAL OF IMMUNOLOGY (2000)